Completed TEMMP Projects

  • Systematic review of the cost-effectiveness of pharmacotherapy for hyperlipidemia
  • Canadian market access landscape assessment for asthma
  • Review of the cost and health-related quality of life associated with diabetes and diabetes-related complications
  • Review and reimbursement landscape assessment of bone mineral density and fractures in men
  • Systematic review and meta-analysis of biologics for the treatment of psoriasis
  • Burden of illness of osteoporosis in Canadian men [journal article]
  • Validation of a global cost-effectiveness model for patients with previously-treated metastatic soft-tissue sarcoma
  • Cost-effectiveness of intranasal live attenuated influenza vaccine versus injectable inactivated vaccine for Canadian children and adolescents [journal article]
  • Cost-effectiveness of treatments for metastatic colorectal cancer patients with non-mutated (wild-type) Kirsten Ras Sarcoma virus (KRAS)
  • Economic burden of illness of atrial fibrillation [journal article]
  • A time in motion study of intravenous bisphosphates in patients with metastatic bone disease
  • Economic burden of illness of osteoporosis [journal article]
  • Cost-effectiveness of a community-level cardiovascular health awareness program
  • Cost-effectiveness of implementing a primary care, multidisciplinary diabetes management program
  • Cost-effectiveness of laparoscopic nissen fundoplication (LNF) versus omeprazole for treatment of patients with chronic gastro-esophageal reflux disease (GERD)
  • Clinical and economic review of recent technologies for the diagnostic testing of glaucoma [journal article]
  • Assessing the feasibility of a national altruistic donor sperm program for Canadians [report]
  • Cost-effectiveness of a Canadian nurse-coordinated multi-risk factor intervention clinic for patients chronic kidney disease [journal article]
  • Cost-effectiveness analysis of casting versus splints in children with wrist fractures [journal article]
  • Cost-effectiveness of etanercept for the treatment of children and adolescents in Canada with plaque psoriasis
  • Review of health utilities across conditions common in paediatric and adult populations [journal article]